BioSpace News Archive

FUJIFILM Medical Systems, U.S.A. , Inc. today announced that the company has selected caresyntax , a pioneering developer in surgical automation, analytics software, as the supplier of Fujifilm Systems Integration using caresyntax’s proprietary operating room (OR) integration and workflow automation intelligence.

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “ Company ” or “ Algernon ”) a clinical stage pharmaceutical development company, is pleased to announce that it has received a No Objection Letter from Health Canada to proceed with a NP-120 (Ifenprodil) COVID-19 Phase 2b/3 multinational clinical trial. The same study protocol is being prepared for submission to the U.S. FDA and Australian regulatory au

Pathline Labs, a leading provider of sub-specialized anatomic pathology, has developed Coronavirus Disease testing at its Ramsey, New Jersey facility.

Data presented on repurposing the existing, broad-spectrum antiviral agent using Thin Film Freezing and other techniques to enhance its effect for COVID-19 therapy

Aravive, Inc., a clinical-stage biopharmaceutical company, and WuXi Biologics, a global company with leading open-access biologics technology platforms, announced a strategic collaboration agreement granting Aravive the right to use the proprietary WuXiBody™ platform to develop high-affinity bispecific antibodies for a target implicated in cancer and fibrosis.

NKMax America disclosed its three abstract titles related to SNK-01, an autologous NK cell adoptive immunotherapy for the upcoming 2020 American Society of Clinical Oncology annual meeting, being held virtually.

Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that it has obtained positive pre-clinical results for its COVID-19 vaccine candidates, with several of the vaccine candidates generating immune responses in all tested animals after a single dose. “These pre-clinical results confirm that all constructs are immunogeni

- Partnership with NJPCA, which represents 23 community health centers in NJ, funded 5 telehealth pilots; programs serving as role models for centers across state - The Grant enabled NJ community health centers to quickly implement telehealth to maintain continuity of care for underserved communities, especially critical during the current COVID-19 pandemic

INOVIO and Richter-Helm BioLogics will expand existing DNA manufacturing agreement to support large-scale manufacturing of INO-4800

Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, today announced that the Company will release its first quarter 2020 financial results before the opening of the U.S. financial markets on Thursday, May 7, 2020. Management will host a conference call at 8